AAAAAA

   
Results: 1-14 |
Results: 14

Authors: Gajewski, TF Fallarino, F Ashikari, A Sherman, M
Citation: Tf. Gajewski et al., Immunization of HLA-A2(+) melanoma patients with MAGE-3 or MelanA peptide-pulsed autologous peripheral blood mononuclear cells plus recombinant humaninterleukin 12, CLIN CANC R, 7(3), 2001, pp. 895S-901S

Authors: Markiewicz, MA Fallarino, F Ashikari, A Gajewski, TF
Citation: Ma. Markiewicz et al., Epitope spreading upon P815 tumor rejection triggered by vaccination with the single class I MHC-restricted peptide P1A, INT IMMUNOL, 13(5), 2001, pp. 625-632

Authors: Alegre, M Fallarino, F Zhou, P Frauwirth, K Thistlethwaite, J Newell, K Gajewski, T Bluestone, J
Citation: M. Alegre et al., Transplantation and the CD28/CTLA4/B7 pathway, TRANSPLAN P, 33(1-2), 2001, pp. 209-211

Authors: Grohmann, U Fallarino, F Bianchi, R Belladonna, ML Vacca, C Orabona, C Uyttenhove, C Fioretti, MC Puccetti, P
Citation: U. Grohmann et al., IL-6 inhibits the tolerogenic function of CD8 alpha(+) dendritic cells expressing indoleamine 2,3-dioxygenase, J IMMUNOL, 167(2), 2001, pp. 708-714

Authors: Grohmann, U Belladonna, ML Vacca, C Bianchi, R Fallarino, F Orabona, C Fioretti, MC Puccetti, P
Citation: U. Grohmann et al., Positive regulatory role of IL-12 in macrophages and modulation by IFN-gamma, J IMMUNOL, 167(1), 2001, pp. 221-227

Authors: Gajewski, TF Fallarino, F Fields, PE Rivas, F Alegre, ML
Citation: Tf. Gajewski et al., Absence of CTLA-4 lowers the activation threshold of primed CD8(+) TCR-transgenic T cells: Lack of correlation with Src homology domain 2-containing protein tyrosine phosphatase, J IMMUNOL, 166(6), 2001, pp. 3900-3907

Authors: Grohmann, U Fallarino, F Silla, S Bianchi, R Belladonna, ML Vacca, C Micheletti, A Fioretti, MC Puccetti, P
Citation: U. Grohmann et al., CD40 ligation ablates the tolerogenic potential of lymphoid dendritic cells, J IMMUNOL, 166(1), 2001, pp. 277-283

Authors: Grohmann, U Bianchi, R Belladonna, ML Silla, S Fallarino, F Fioretti, MC Puccetti, P
Citation: U. Grohmann et al., IFN-gamma inhibits presentation of a tumor/self peptide by CD8 alpha(-) dendritic cells via potentiation of the CD8 alpha(+) subset, J IMMUNOL, 165(3), 2000, pp. 1357-1363

Authors: Kacha, AK Fallarino, F Markiewicz, MA Gajewski, TF
Citation: Ak. Kacha et al., Spontaneous rejection of poorly immunogenic P1.HTR tumors by Stat6-deficient mice, J IMMUNOL, 165(11), 2000, pp. 6024-6028

Authors: Fallarino, F Grohmann, U Bianchi, R Vacca, C Fioretti, MC Puccetti, P
Citation: F. Fallarino et al., Th1 and Th2 cell clones to a poorly immunogenic tumor antigen initiate CD8(+) T cell-dependent tumor eradication in vivo, J IMMUNOL, 165(10), 2000, pp. 5495-5501

Authors: Griffin, MD Hong, DK Holman, PO Lee, KM Whitters, MJ O'Herrin, SM Fallarino, F Collins, M Segal, DM Gajewski, TF Kranz, DM Bluestone, JA
Citation: Md. Griffin et al., Blockade of T cell activation using a surface-linked single-chain antibodyto CTLA-4 (CD152), J IMMUNOL, 164(9), 2000, pp. 4433-4442

Authors: Silla, S Fallarino, F Boon, T Uyttenhove, C
Citation: S. Silla et al., Enhancement by IL-12 of the cytolytic T lymphocyte (CTL) response of mice immunized with tumor-specific peptides in an adjuvant containing QS21 and MPL, EUR CYTOKIN, 10(2), 1999, pp. 181-189

Authors: Fallarino, F Gajewski, TF
Citation: F. Fallarino et Tf. Gajewski, Cutting edge: Differentiation of antitumor CTL in vivo requires host expression of Stat1, J IMMUNOL, 163(8), 1999, pp. 4109-4113

Authors: Fallarino, F Uyttenhove, C Boon, T Gajewski, TF
Citation: F. Fallarino et al., Improved efficacy of dendritic cell vaccines and successful immunization with tumor antigen peptide-pulsed peripheral blood mononuclear cells by coadministration of recombinant murine interleukin-12, INT J CANC, 80(2), 1999, pp. 324-333
Risultati: 1-14 |